{
    "Overall_score": {
        "Correlation": 7,
        "Sentiment": 6,
        "Importance": 6,
        "Impact": 5,
        "Duration": 8,
        "Virality": 4,
        "Source_Score": 7,
        "Specificity": 6,
        "Sector_Spread": 7,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "JNJ 2014 - Why The Ride Isn't Over [Facebook Inc, Johnson & Johnson, JPMorgan",
            "Correlation": 6,
            "Sentiment": 7,
            "Importance": 5,
            "Impact": 4,
            "Duration": 7,
            "Virality": 5,
            "Source_Score": 6,
            "Specificity": 5,
            "Sector_Spread": 8,
            "Tech_Mentions": 2
        },
        {
            "News_content": "JNJ Morning Dow Report: Will a Telecom Price War Hurt AT&T and Verizon?",
            "Correlation": 8,
            "Sentiment": 5,
            "Importance": 7,
            "Impact": 6,
            "Duration": 9,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 7,
            "Sector_Spread": 6,
            "Tech_Mentions": 3
        },
        {
            "News_content": "JNJ Why Big Pharma Isn't Scared of Biosimilars",
            "Correlation": 7,
            "Sentiment": 6,
            "Importance": 6,
            "Impact": 5,
            "Duration": 8,
            "Virality": 3,
            "Source_Score": 7,
            "Specificity": 7,
            "Sector_Spread": 7,
            "Tech_Mentions": 2
        }
    ]
}